TEMA MEDICINA S.R.L. – Trademark Portfolio

Entity Type: 16

TEMA MEDICINA S.R.L. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ATTIVA and UNICA DUAL ENERGY SYSTEM. The owner is based in BOLOGNA.

VIA DEI FORNACIAI 29/E

BOLOGNA 40129 , IT

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TEMA MEDICINA S.R.L.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does TEMA MEDICINA S.R.L. have?

TEMA MEDICINA S.R.L. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does TEMA MEDICINA S.R.L. file in?

TEMA MEDICINA S.R.L. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are TEMA MEDICINA S.R.L.'s most well-known trademarks?

TEMA MEDICINA S.R.L.'s registered trademark portfolio includes well-known marks such as ATTIVA and UNICA DUAL ENERGY SYSTEM. These are among 2 currently registered trademarks in the portfolio.

What is TEMA MEDICINA S.R.L.'s trademark registration success rate?

TEMA MEDICINA S.R.L. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.